Fajac A, Vidaud M, Lebargy F, Stephan F, Ricci S, Geslin P, Goossens M, Bernaudin J F
Inserm Unit 139, Hôpital Henri Mondor, Creteil, France.
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):495-9. doi: 10.1164/ajrccm.149.2.8306052.
Cytomegalovirus (CMV) pneumonia is a major cause of illness in immunocompromised patients. The sites of human CMV (HCMV) latency are still not clearly defined. The present study was therefore designed to investigate the hypothesis that alveolar macrophages could constitute such a site. DNA extracted from alveolar cells collected by bronchoalveolar lavage and blood mononuclear cells (BMC) from asymptomatic nonimmunocompromised CMV-seropositive and CMV-seronegative patients were investigated. Controls consisted of DNA from a CMV-infected MRC5 cell line, BMC and alveolar macrophages from patients with acute CMV infection. Polymerase chain reaction (PCR) was designed for detection of a 290-bp fragment of the promoter region of the major immediate early gene of HCMV conserved within the various HCMV strains and without homology with the human genome. The limit of detection of the method was evaluated to be one HCMV viral copy per 10(4) cells. HCMV DNA was detected in BMC or alveolar cells of all patients with acute CMV infection. In contrast, no HCMV DNA was detected in alveolar cells and BMC from nonimmunocompromised asymptomatic HCMV-seropositive patients. In conclusion, in the present experiment, no latent HCMV could be detected in alveolar cells collected in nonimmunocompromised asymptomatic CMV-seropositive patients.
巨细胞病毒(CMV)肺炎是免疫功能低下患者患病的主要原因。人巨细胞病毒(HCMV)潜伏部位仍未明确界定。因此,本研究旨在探讨肺泡巨噬细胞可能构成这样一个潜伏部位的假说。对通过支气管肺泡灌洗收集的肺泡细胞以及无症状非免疫功能低下的CMV血清阳性和CMV血清阴性患者的血液单核细胞(BMC)提取的DNA进行了研究。对照组包括来自CMV感染的MRC5细胞系的DNA、急性CMV感染患者的BMC和肺泡巨噬细胞。设计聚合酶链反应(PCR)用于检测HCMV主要立即早期基因启动子区域的一个290 bp片段,该片段在各种HCMV毒株中保守且与人类基因组无同源性。该方法的检测限评估为每10(4)个细胞一个HCMV病毒拷贝。在所有急性CMV感染患者的BMC或肺泡细胞中均检测到HCMV DNA。相比之下,在非免疫功能低下的无症状HCMV血清阳性患者的肺泡细胞和BMC中未检测到HCMV DNA。总之,在本实验中,在非免疫功能低下的无症状CMV血清阳性患者收集的肺泡细胞中未检测到潜伏的HCMV。